Member LoginMember Login - User registration - Setup as front page - Add to favorites - Sitemap Why Amylyx is pulling ALS drug Relyvrio from US market after study !

Why Amylyx is pulling ALS drug Relyvrio from US market after study

Time:2024-05-21 21:29:18 source:Stellar Station news portal

WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.

Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.

“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.

The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.

Related information
  • Shooting injures 2 at Missouri high school graduation ceremony
  • VOX POPULI: What jobs do children want to take in the future?
  • Petrobras paid BRL 240.2 bi in taxes and royalties in 2023
  • AUKUS, Gaza on agenda during Winston Peters
  • Eleanor Tomlinson puts on a leggy display in sparkly black minidress as she joins co
  • Splore festival to take 2025 off after posting loss
  • Yan Chenglong: Chinese chess champ dethroned after defecating and sex toy cheat claims
  • IDB, Brazil’s Central Bank sign agreement to support green investments
Recommended content
  • Kevin Pillar gets 1,000th career hit in Angels' win at Texas
  • Prime Minister Anthony Albanese meets with Chinese President Xi Jinping
  • At least 3 shot during Eid al
  • As it happened: Rain lashes North and South Islands
  • Jodie Turner
  • Teenager targeted, run over multiple times, police say